Adjuvant therapy for renal cell carcinoma, finally a new standard?

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,064 followers.

RT @FrontOncology: Most Viewed Perspective Article of our #CancerGenetics section: Adjuvant therapy for #renalcellcarcinoma, finally a new…

Adjuvant therapy for renal cell carcinoma, finally a new standard? https://t.co/QXvxXyf978 https://t.co/KLdTEJchhF

Most Viewed Perspective Article of our #CancerGenetics section: Adjuvant therapy for #renalcellcarcinoma, finally a new standard? 👨‍⚕️👩‍⚕️ Alex Renner et al Read here 👉 https://t.co/7PxWMbI0Nm @annerleim @BurottoMauricio

Adjuvant therapy for renal cell carcinoma, finally a new standard?https://t.co/xSLiVHLsIO

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.